Merkliste 
 1 Ergebnisse 
 
1

Adalimumab medium-term dosing strategy in moderate-to-sever..:

Jemec, G.B.E. ; Okun, M.M. ; Forman, S.B....
British Journal of Dermatology.  181 (2019)  5 - p. 967-975 , 2019